# Cytisine Compared to Combination NRT in Relapsed Smokers

> **NCT04286295** · NA · TERMINATED · sponsor: **Ottawa Heart Institute Research Corporation** · enrollment: 13 (actual)

## Conditions studied

- Smoking Cessation
- Coronary Artery Disease

## Interventions

- **DRUG:** Cytisine
- **DRUG:** Nicoderm C-Q Transdermal Product
- **DRUG:** Nicorette Lozenge Product

## Key facts

- **NCT ID:** NCT04286295
- **Lead sponsor:** Ottawa Heart Institute Research Corporation
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-03-14
- **Primary completion:** 2023-11-07
- **Final completion:** 2023-11-07
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** Feasibility
- **Last updated:** 2023-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04286295

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04286295, "Cytisine Compared to Combination NRT in Relapsed Smokers". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04286295. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*